Table 1 Demographics and clinical characteristics of total cohort and subsets
From: Predictive ability of EuroSCORE II integrating cardiactroponin T in patients undergoing OPCABG
Variables | Total (n = 1887) | cTnT group (n = 971) | hs-cTnT group (n = 916) | P |
|---|---|---|---|---|
Age (y) | 64.94 (60;71) | 65.15 (60;71) | 64.70 (60;71) | 0.413 |
Female (n, %) | 460 (24.4) | 236 (24.3) | 224 (24.5) | 0.940 |
Weight (kg) | 68.88 (61;69) | 69.14 (61;76) | 68.61 (60;75) | 0.115 |
Height (cm) | 166.52 (160;172) | 166.53 (160;172) | 166.51 (160;172) | 0.851 |
BMI (kg/m2) | 24.79 (22.83;26.67) | 24.89 (22.86;26.85) | 24.69 (22.66;26.52) | 0.066 |
BSA (m2) | 1.74 (1.63;1.85) | 1.75 (1.63;1.86) | 1.74 (1.62;1.84) | 0.226 |
Diabetes (n, %) | 590 (31.3) | 324 (33.4) | 266 (29.0) | 0.043 |
Hypertention (n, %) | 1281 (68.4) | 722 (74.4) | 569 (62.1) | 0.000 |
Cr (μmol/l) | 82.44 (64.80;90.10) | 83.99 (68.00;91.90) | 80.79 (62.43;86.00) | 0.000 |
Ccr (mL/min/1.73 m2) | 80.87 (63.31;95.83) | 78.69 (62.17;93.39) | 83.16 (64.86;99.32) | 0.000 |
Renal failure (n, %) | 29 (1.5) | 11 (1.1) | 18 (2.0) | 0.236 |
Myocardial injury classification | Â | Â | Â | 0.212 |
 Stage 1 (n, %) | 1322 (70.1) | 894 (92.1) | 428 (46.7) |  |
 Stage 2 (n, %) | 455 (24.1) | 66 (6.8) | 389 (42.5) |  |
 Stage 3 (n, %) | 45 (2.4) | 6 (0.6) | 39 (4.3) |  |
 Stage 4 (n, %) | 65 (3.4) | 5 (0.5) | 60 (6.6) |  |
 Cerebrovascular disease (n, %) | 350 (18.5) | 254 (26.2) | 96 (10.5) | 0.100 |
 COPD (n, %) | 54 (2.9) | 21 (2.2) | 33 (3.6) | 0.311 |
 Peripheral vascular disease (n, %) | 47 (2.5) | 30 (3.1) | 17 (1.9) | 0.517 |
 Previous PCI (n, %) | 115 (6.1) | 31 (3.2) | 84 (9.2) | 0.296 |
 Atrial flutter and fibrillation (n, %) | 66 (3.5) | 34 (3.5) | 32 (3.5) | 0.385 |
 Combined valvular disease (n, %) | 249 (13.2) | 71 (7.3) | 178 (19.4) | 0.001 |
 Pulmonary hypertension (n, %) | 179 (9.5) | 21 (2.2) | 158 (17.2) | 0.177 |
Types of CAD | Â | Â | Â | 0.000 |
 AMI (n, %) | 260 (13.8) | 161 (16.6) | 99 (10.8) |  |
 Unstable angina (n, %) | 1028 (54.5) | 567 (58.4) | 461 (50.3) |  |
 Number of diseased vessels (n) | 2.85 (3;3) | 2.85 (3;3) | 2.85 (3;3) | 0.459 |
NYHA | Â | Â | Â | 0.002 |
 I (n, %) | 217 (31.7) | 67 (6.9) | 150 (16.4) |  |
 II (n, %) | 1229 (65.1) | 684 (70.4) | 545 (59.5) |  |
 III (n, %) | 404 (21.4) | 202 (20.8) | 202 (22.1) |  |
 IV (n, %) | 37 (2) | 18 (1.9) | 19 (2.1) |  |
 LVEF (%) | 60.92 (59.9;65.4) | 61.75 (60.0;65.9) | 60.03 (58.0;65.2) | 0.000 |
 EuroSCORE II | 1.68 (0.94;2.03) | 1.82 (1.01;2.22) | 1.53 (0.85;1.80) | 0.000 |
 Bypass graft number (n) | 3.54 (3;4) | 3.54 (3;4) | 3.55 (3;4) | 0.444 |
 In-hospital mortality (n, %) | 43 (2.3) | 21 (2.2) | 22 (2.4) | 0.155 |